UpToDate®

Abstract

UpToDate| April 2023 UpToDate® ASA Monitor April 2023, Vol. 87, 17. https://doi.org/10.1097/01.ASM.0000924968.10690.12 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Search Site Citation UpToDate®. ASA Monitor 2023; 87:17 doi: https://doi.org/10.1097/01.ASM.0000924968.10690.12 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll PublicationsASA Monitor Search Advanced Search Topics: guidelines, induction of neuromuscular blockade, lung cancer, neuromuscular blockade monitoring, preoperative exercise, surgery specialty, surgical procedures, operative UpToDate® and ASA Monitor are collaborating to present select content abstracts on “What's New in Anesthesiology.” UpToDate is an evidence-based, clinical support resource used worldwide by health care practitioners to make decisions at the point of care. For complete, current “What's New” content, or to become a subscriber for full content access, go to www.uptodate.com. “What's New” abstract information is free for all medical professionals. Both the American Society of Anesthesiologists (ASA) and European Society of Anaesthesiology and Intensive Care (ESAIC) have published new guidelines on the management of neuromuscular blockade during anesthesia.1,2 In addition to other recommendations, both guidelines strongly recommend using quantitative neuromuscular monitoring (e.g., electromyography or accelerometry) rather than qualitative assessment and confirming a train-of-four ratio ≥0.9 before extubation. They also recommend using sugammadex for reversal rather than neostigmine for patients who have received rocuronium or vecuronium and who have residual block at... You do not currently have access to this content.